Prothena Corporation plc (PRTA)
NASDAQ·Healthcare·Biotechnology
$7.94
-0.38%
Mkt Cap $405.05M
Analyst Ratings
No recent rating data.
Price Target (15 analysts)
$30.00
Range $30.00 – $30.00
Implied Upside
+277.8%
Consensus $30.00 vs current $7.94
NASDAQ·Healthcare·Biotechnology
$7.94
-0.38%
Mkt Cap $405.05M
No recent rating data.
Price Target (15 analysts)
$30.00
Range $30.00 – $30.00
+277.8%
Consensus $30.00 vs current $7.94